• Issue

    Journal of Surgical Oncology: Volume 104, Issue 3

    223-335
    1 September 2011
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Research Articles

An evidence based strategy for follow up after breast conserving treatment for breast cancer

Michael Kontos MD,  Pratik Roy MB, MRCS,  Demetrios Rizos PhD,  Hisham Hamed PhD, FRCS, 
  • Pages: 223-227
  • First Published: 02 March 2011

The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue

Kelvin Y.M. Chong MRCS, MD,  Ashok Subramanian FRCS,  Kefah Mokbel FRCS, MS,  Anup K. Sharma FRCS, MS, 
  • Pages: 228-235
  • First Published: 07 April 2011

CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: A tissue array analysis† ‡

Kong-Jia Luo MD,  Yi Hu MD, PhD,  Jing Wen MD,  Jian-Hua Fu MD, PhD, 
  • Pages: 236-243
  • First Published: 07 April 2011

Biological reconstruction using massive bone allograft with intramedullary vascularized fibular flap after intercalary resection of humeral malignancy† ‡

Jing Li MD, PhD,  Zhen Wang MD, PhD,  Guo-Xian Pei MD, PhD,  Zheng Guo MD, PhD, 
  • Pages: 244-249
  • First Published: 01 April 2011

Surgical implications of mesenteric lymph node metastasis from advanced ovarian cancer after bowel resection

Glauco Baiocchi MSc, MD,  Lourival Augusto Cestari MD,  Mariana Petaccia Macedo MD,  Renato Almeida Rosa Oliveira MD,  Elza Mieko Fukazawa MSc, MD,  Carlos Chaves Faloppa MD,  Lillian Yuri Kumagai MD,  Levon Badiglian-Filho MD, PhD,  Ademir Narciso Oliveira Menezes MD,  Isabela Werneck Cunha MD, PhD,  Fernando Augusto Soares MD, PhD, 
  • Pages: 250-254
  • First Published: 06 April 2011

Class II radical hysterectomy for stage I–IIA cervix cancer: Prognostic factors associated to recurrence and survival in a northeast Brazil experience†

Artur Lício Rocha Bezerra MD, PhD,  Mário Rino Martins MD, MS,  Simone Maria Muniz da Silva Bezerra PhD,  José Natal Figueiroa MS,  Thales Paulo Batista MD, MS, 
  • Pages: 255-259
  • First Published: 04 April 2011

Honokiol produces anti-neoplastic effects on melanoma cells in vitro†

Patrick W. Mannal MD,  John Schneider MD,  Abhilasha Tangada MD,  Debbie McDonald BS,  David W. McFadden MD, MBA, FACS, 
  • Pages: 260-264
  • First Published: 06 April 2011

Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphoma

Yi-Ling Lai MD,  Jen-Kou Lin MD, PhD,  Wen-Yih Liang MD,  Yu-Chung Huang MD,  Shih-Ching Chang MD, PhD, 
  • Pages: 265-268
  • First Published: 06 April 2011

Unresectable peritoneal carcinomatosis from colorectal cancer: A single center experience

Daphne Hompes MD,  Henk Boot MD, PhD,  Harm van Tinteren PhD,  Victor Verwaal MD, PhD, 
  • Pages: 269-273
  • First Published: 04 April 2011

Is routine measurement of amylase concentration in drainage fluid necessary after total gastrectomy for gastric cancer?

Yoshito Tomimaru MD,  Isao Miyashiro MD, PhD,  Kentaro Kishi MD, PhD,  Masaaki Motoori MD, PhD,  Masahiko Yano MD, PhD,  Tatsushi Shingai MD, PhD,  Shingo Noura MD, PhD,  Masayuki Ohue MD, PhD,  Hiroaki Ohigashi MD, PhD,  Osamu Ishikawa MD, PhD, 
  • Pages: 274-277
  • First Published: 14 April 2011

Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell

Jing Zhou MD,  Wei Wang MD, PhD, 
  • Pages: 278-283
  • First Published: 14 April 2011

Prognosis of patients with hepatocellular carcinoma after hepatic resection: Are elderly patients suitable for surgery?

Atsushi Nanashima MD,  Takafumi Abo MD,  Takashi Nonaka MD,  Hidetoshi Fukuoka MD,  Shigekazu Hidaka MD,  Hiroaki Takeshita MD,  Tatsuki Ichikawa MD,  Terumitsu Sawai MD,  Toru Yasutake MD,  Kazuhiko Nakao MD,  Takeshi Nagayasu MD, 
  • Pages: 284-291
  • First Published: 01 April 2011

Outcomes of hepatic resection for huge hepatocellular carcinoma (≥10 cm in diameter)

Yo-ichi Yamashita MD, PhD,  Akinobu Taketomi MD, PhD,  Ken Shirabe MD, PhD,  Shinichi Aishima MD, PhD,  Eiji Tsuijita MD, PhD,  Kazutoyo Morita MD,  Hiroto Kayashima MD,  Yoshihiko Maehara MD, PhD, FACS, 
  • Pages: 292-298
  • First Published: 04 April 2011

Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma

Ming-Hsien Chien PhD,  Kun-Tu Yeh MD,  Yi-Ching Li PhD,  Yi-Hsien Hsieh PhD,  Chien-Huang Lin PhD,  Meng-Shih Weng PhD,  Wu-Hsien Kuo MD, PhD,  Shun-Fa Yang PhD, 
  • Pages: 299-304
  • First Published: 01 April 2011

Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer

Yogesh K. Vashist MD,  Guentac Uzungolu MD,  Asad Kutup MD,  Florian Gebauer MD,  Alexandra Koenig MD,  Lena Deutsch MD,  Oliver Zehler MD,  Philipp Busch MD,  Viacheslav Kalinin PhD,  Jakob R. Izbicki MD, FACS,  Emre F. Yekebas MD, 
  • Pages: 305-311
  • First Published: 14 April 2011

How I Do It

Intragastric approach for submucosal tumors located near the Z-line: A hybrid laparoscopic and endoscopic technique

Jung Ho Shim MD,  Han Hong Lee MD,  Han Mo Yoo MD,  Hae Myung Jeon MD,  Cho Hyun Park MD,  Jun Gi Kim MD,  Kyo Young Song MD, 
  • Pages: 312-315
  • First Published: 04 April 2011

Review Articles

Thrombophilic state in cancer, Part I: Biology, incidence, and risk factors

Peter J. DiPasco MD,  Subhasis Misra MD,  Leonidas G. Koniaris MD,  Frederick L. Moffat Jr. MD, MBA, 
  • Pages: 316-322
  • First Published: 07 April 2011

The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery†

Boudewijn E. Schaafsma MD,  J. Sven D. Mieog MD,  Merlijn Hutteman MSc,  Joost R. van der Vorst MD,  Peter J.K. Kuppen PhD,  Clemens W.G.M. Löwik PhD,  John V. Frangioni MD, PhD,  Cornelis J.H. van de Velde MD, PhD,  Alexander L. Vahrmeijer MD, PhD, 
  • Pages: 323-332
  • First Published: 14 April 2011

Letters to the Editor

Reply to a letter to the editor for “Impact of site of lymph node metastasis in patients with thoracic esophageal cancer”

Chikara Kunisaki MD, PhD, 
  • Page: 333
  • First Published: 03 August 2011

Impact of lymph-node metastasis site in patients with thoracic esophageal cancer: Does the lymph node metastasis site matter?

Kang-Ning Wang MD,  Qi-Rong Xu MD,  Long-Qi Chen MD, PhD, 
  • Page: 334
  • First Published: 03 August 2011

Novel techniques for imaging and diagnosing neuroendocrine tumours

Rajaventhan Srirajaskanthan MD, MRCP,  Sandra Easdale PhD, MBBS, 
  • Page: 335
  • First Published: 08 March 2011